Is it the time to shift paradigms in castration naive prostate cancer (CNPC): A meta-analysis of upfront docetaxel and abiraterone in men with CNPC.-MedSci.cn

Is it the time to shift paradigms in castration naive prostate cancer (CNPC): A meta-analysis of upfront docetaxel and abiraterone in men with CNPC.

Sun, GX; Zhang, XM; Chen, JR; Liao, BH; Zhao, JG; Shen, PF; Zeng, H

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (6):

科室
- - 订阅+
  - 更多科室
工具
服务